A significantly lower LVPWd in AAV9-TLR2-injected mice than in AAV9-control-injected mice repressed dilated cardiomyopathy; moreover, the cardiac-specific overexpression of TLR2 aggravated TAC-induced cardiac dysfunction. This evidence concerns the gene TLR2 and dilated cardiomyopathy.